Unknown PHASE4 INTERVENTIONAL 2-arm NCT00883532

Prevention of Chronic Lung Disease (CLD) in Preterm Infants

Prevention of Chronic Lung Disease (CLD) in Preterm Infants -A New Therapeutic Regimen

Sponsor: Cathay General Hospital

Conditions Chronic Lung Disease of Prematurity Respiratory Distress Syndrome

Interventions budesonide surfactant and air (placebo)

Updated 5 times since 2017 Last updated: Aug 7, 2012 Started: Apr 30, 2009 Primary completion: Dec 31, 2012 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00883532, this PHASE4 trial focuses on Chronic Lung Disease of Prematurity and Respiratory Distress Syndrome and remains ongoing. Sponsored by Cathay General Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cathay General Hospital
Chang Gung Memorial Hospital
China Medical University, China
National Taiwan University Hospital
Taipei Medical University Hospital

Data source: China Medical University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, China